CAPA In-vitro Oocyte Maturation (CUHK Medical Centre Limited)

CAPA In-vitro Oocyte Maturation

In vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lower health risk profile of IVM compared to controlled ovarian stimulation (COS) in polycystic ovary syndrome (PCOS) patients, the use of IVM in selected patients may gain increasing interest. Besides its application in patients with polycystic ovaries, IVM technology may have a role in fertility preservation, where young girls and adult women are facing infertility due to gonadotoxic chemotherapeutic treatment.

Inclusion Criteria:

• Patients aged from 18-50 years old
• Patients seek fertility preservation services
• Patients seek oocyte retrieval services

Exclusion Criteria:

• Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)